Hong Kong Stock Afternoon Review|Hang Seng Index rose 0.01% in early trading, biopharmaceuticals lead blue chip stocks

The Zhitong Finance App learned that the Hong Kong Stock Hang Seng Index rose 0.01%, up 3 points to 23,529 points; the Hang Seng Technology Index fell 1.02%. Hong Kong stocks traded HK$87.7 billion in early trading.

Biomedicine is leading the blue chip increase. Yao Ming Biotech (02269) rose 4.88% to win the largest biosimilar development order. UBS gave a target price of HK$62; Rongchang Biotech (09995) increased 5.12%; and Pharmaceutical Kangde (02359) rose 5.45%.

Xiying-W (00625) rose 5.5%, and the company paid 100 million US dollars to settle the FTC investigation. The agency indicated that demand in the US and European markets is expected to recover one after another.

Zhaowei Mechatronics (02692) rose 9.9%, and the company's dexterous and core drive modules have strong market competitiveness.

Winner Vogue (03709) rose more than 13% and declared a special dividend of HK82 cents per share, corresponding to a dividend rate of approximately 19.7%.

True Health Medical-B (02697) increased by more than 20%. Grassroots applications of piercing robots showed promotion potential, and the commercialization process continued to accelerate.

May Day Vision (06651) rose more than 8%. The founder voluntarily extended the sales ban for four years, and the company's card is on the physical AI infrastructure circuit.

SF Express Tongcheng (09699) rose more than 4%. Recently, it renewed its cooperation framework agreement with SF Holdings to lock in a three-year long-term cooperation.

CIMC Group (02039) rose 3%, signed a strategic cooperation agreement with the Oman Sovereign Fund, and placed orders for the company's modular data center.

Sany International (00631) fell 4%, and its stock price fell by nearly 20% after the results. The agency claimed that its stock price correction was excessive.

Ideal Automobile-W (02015) fell 3.6%, Ideal i6 is being replaced, and Ideal's October delivery volume fell below 30,000.

Bruker (00325) fell more than 8%, and after the controlling shareholder reduced their holdings, it fell 26%. Citi indicated that short-term investor sentiment was under pressure.